Scholars Central

EditorialPublished 28 Aug 2023

Phase 2 Study Shows Positive Impact of New Therapeutic Agent

Authors: Wendell Moses

Annals of Clinical Trials and Vaccines Research

Volume 13 · Issue 4 · Pages 121–124

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A Phase 2 clinical trial is a critical stage in the process of testing new medical treatments, therapies, or interventions on human subjects. It follows the initial Phase 1 trial, which primarily focuses on safety and dosage determination in a small group of healthy volunteers or patients. In Phase 2, the study expands to involve a larger population of participants, typically ranging from several dozen to a few hundred individuals. During a Phase 2 trial, the focus shifts to a larger group of patients or participants who have the specific condition or disease that the medical intervention aims to target. The primary objectives of this phase are to further assess the treatment’s safety, dosage range, and potential side effects while also gaining preliminary evidence of its effectiveness in treating the targeted condition. The trial design in Phase 2 is more controlled and structured, involving randomized, controlled studies with a placebo or standard-of-care comparison group. This allows researchers to carefully measure and analyze the treatment’s impact on the participants’ health outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Clinical Trials and Vaccines Research
  • SubjectPharmaceutical Sciences
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Wendell Moses”